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Background and Aim: There is a long history of brain stimulation in medical science, and it was tested for years 
trying to treat several neurological diseases. On the other hand, the treatment choices for patients with severe brain 
injury resulting in disorders of consciousness (DOC) are still limited and research in this field remains challenging. 
In the current literature, only a few techniques of brain stimulation were studied in this population of patients. This 
review describes noninvasive techniques, namely transcranial magnetic stimulation (TMS) and transcranial direct 
current stimulation (tDCS), which permit to stimulate the brain through the scalp, as well as the current status of 
deep brain stimulation (DBS) as treatment for patients with DOC. For each technique (i.e. TMS, tDCS and DBS) a 
systematic search on Pubmed was performed including the term “vegetative state” or “minimally conscious state” or 
“disorders of consciousness” and 16 articles matched the criteria.  
Conclusion: Currently, repetitive TMS (rTMS) and tDCS studies have shown encouraging results, with transient 
improvements of behavioral signs of consciousness in patients in minimally conscious state (MCS). DBS showed 
more impressive and extensive behavioral improvement after the implantation of an electrical stimulator in the 
thalamus. However, this procedure is riskier and the number of patients who can benefit from this intervention is 
limited. All these therapeutic approaches are still in their infancy. In the years to follow, controlled clinical studies 
on potential treatments for patients with DOC should multiply and therapeutic measures should be more accessible, 
controlled and effective. 
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Patients with disorders of consciousness (DOC) have 
great impacts on public health. Two such conditions are the 
vegetative state (VS), renamed unresponsive wakefulness 
syndrome (UWS) and the minimally conscious state 
(MCS). VS/UWS clinically means the patient is awake, but 
fully unconscious of him/herself and his/her environment 
(1,2). MCS essentially differs from VS/UWS by the 
evidence of a partial preservation of awareness (3). This 




(e.g., visual pursuit, localization of noxious stimulation 
and/or smiling/crying in contingent relationship to external 
stimuli) and “MCS plus” (e.g., higher-level behavioral 
responses such as command following).4  
While significant progress has been made in 
understanding the neural correlates of consciousness 
disorders, treatment options for patients with altered state 
of consciousness available today remain poor. Moreover, 
when these treatments are efficient, the mechanisms 
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underlying the effects are still almost unknown. However, 
recent discoveries about brain inherent plastic ability could 
offer a range of therapeutic possibilities. This could allow 
brain’s activity to be modulated through its innate 
properties of plasticity and it could help to increase the 
chances of recovery of patients with severe brain injury (5). 
In this review, we will describe the use of noninvasive brain 
stimulation (i.e., transcranial magnetic stimulation – TMS; 
transcranial direct current stimulation - tDCS) and deep 
brain stimulation (DBS) to improve the recovery of patients 
with DOC. Briefly, the use of non-invasive brain 
stimulation techniques (TMS and tDCS) to disentangle 
patients in MCS form patients in VS/UWS will be 
presented. Finally, we will expose a hypothesis to explain 
the mechanism of action of these brain stimulation 
techniques that improve patients’ sign of consciousness, the 
mesocircuit model.  
 
Methods 
Literature search and study selection 
In this review we aimed to identify the clinical trials or 
case reports performed on patients with DOC using brain 
stimulation techniques. We focused our research on three 
different techniques: TMS (including rTMS), tDCS and 
DBS. The medical search engine PubMed was 
systematically screened to identify articles in English 
studying brain stimulation in patients with disorders of 
consciousness. For brain stimulation, the following terms 
were included: “transcranial magnetic stimulation”, 
“repeated transcranial magnetic stimulation”, “transcranial 
direct current stimulation” or “deep brain stimulation”. 
Each term were associated with terms referring to disorders 
of consciousness: “vegetative state”, “unresponsive 
wakefulness syndrome”, “minimally conscious state” or 
“disorders of consciousness.” We included clinical trials 
and case report that assessed patients’ consciousness using 
validated scales and we excluded reviews. For TMS, 1 
article matched the inclusion criteria and 3 for rTMS.  We 
identified 4 articles for tDCS and 8 for DBS that matched 
the inclusion criteria.  
 
Transcranial Magnetic Stimulation (TMS) 
TMS has been used since the 1980’s in neurological 
and psychiatric disorders research. This technique allows 
stimulating the cerebral cortex in a noninvasive way by 
generating a brief but strong magnetic pulse. This pulse is 
send through a coil applied tangentially to the surface of the 
scalp. The fast change in magnetic field strength induces a 
current flow in the tissue, which results in the activation of 
the neurons, and especially the bent axons underlying the 
stimulation (6).  
TMS in DOC was historically first applied to the motor 
cortex with a single pulse protocol. Responses of brain 
stimulation were recorded by electromyography of the 
peripheral muscles and behavioral assessment were 
performed to evaluated the responses derived from the 
TMS stimulation (7). Since the 2000’s, TMS has been 
combined with high-density-electroencephalography 
(EEG), to directly measure the activity of the brain itself. 
This enables study of cortical excitability under the site of 
stimulation, and long-range cortical effective connectivity 
(i.e., causal interactions between distant brain areas) with 
good spatio-temporal resolution (8,9). Using this combined 
TMS-EEG approach, teams from Milan, Liège and 
Madison built the Perturbational Complexity Index (PCI) 
to classify the level of consciousness of patients or healthy 
subjects (10). The PCI estimates brain complexity, 
including both the information content and the integration 
of brain activations, through algorithmic compressibility. 
Briefly, using an algorithm that measures the 
electrophysiological activity induced by TMS, PCI provides 
information on “how much this evoked activity can be 
compressed”.  PCI values are comprised between 0.1 (not 
complex activity recorded and high compressibility) and 0.7 
(highly complex activity recorded and low compressibility. 
For example, the PCI is invariably above 0.31 in healthy 
awake subjects, in patients in MCS or patients in locked-in 
syndrome, as well as in healthy subjects in REM sleep. In 
contrast, the PCI is always below a 0.31 threshold during 
deep sleep, in both VS/UWS patients and in those under 
general anesthesia using midazolam, propofol or xenon 
(Figure 1).   
 
Repetitive TMS 
Repetitive TMS (rTMS) can influence brain plasticity 
and cortical organization through stimulation-induced 
alterations in neuronal excitability. It has been used to 
induce a sustained inhibition (~1Hz frequency) or activation 
(5-20 Hz frequency) of the neuronal population, which 
Figure 1: The Perturbational Complexity Index (PCI). PCI 
measured during consciousness ranged between 0.44 and 0.67, 
whereas the PCI measured during unconsciousness ranged 
between 0.12 and 0.31. PCI values in severely brain-injured 
patients. PCI progressively increases from vegetative 
state/unresponsive wakefulness (VS/UWS) to minimally conscious 
(MCS) and to recovery of functional communication (EMCS). PCI 
attains levels of healthy awake subjects in LIS patients. CRS-R: 
Coma Recovery Scale-Revised. From Casali et al., 2013. 
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allowed stimulating brain areas while observing the 
subsequent behavioral and cognitive changes.11 Higher 
stimulations at 50 Hz, or theta burst stimulations, were also 
performed and showed a suppression of specific excitatory 
circuits in the human motor cortex (12,13). In the literature 
several studies demonstrated positive effects of rTMS in 
people with motor disorders and psychiatric conditions 
(e.g., depression or schizophrenia)(14,15). These findings 
suggest that rTMS may be a promising therapeutic option 
for patients with severe brain injury. Pape et al. performed 
30 high frequency rTMS sessions on the left dorsolateral 
prefrontal (DLPF) cortex in a patient with DOC (16). 
Results were encouraging since the 26 year old patient, who 
was initially in VS/UWS (286 days after a TBI), improved 
to MCS after 15 sessions and stay in this state for the rest of 
the protocol and up to 6 weeks after the end of the 
stimulations. Another case report performed on a 70 years 
old patients in MCS for 5 years, showed a behavioral 
improvement following rTMS over M1 (10 trains of 
100stimulat at 20 Hz fro 10 minutes) (17). The authors 
assessed the effects using the Coma Recovery Scale-Revised 
(CRS-R) and EEG. The patient showed behavioral 
improvement after rTMS as well as an increase in alpha, 
low and high beta activity. A third study investigated the 
effects of a single rTMS session on 6 chronic (> 12months 
post insult) patients with DOC, 3 were diagnosed as being 
in MCS and the other 3 in VS/UWS (18). The stimulation 
was performed over M1, with 1000 stimuli delivered in 10 
trains of 20 Hz, each train lasting 5s with a 20 s inter-train 
pause. Only one patient in MCS showed behavioral 
improvement, as measured by the CRS-R. The authors also 
identified an increase in motor evoked potential (MEP) 
amplitude in all 6 patients. Even if behavioral improvement 
was observed in only 1 MCS patient, the results of the 
physiological outcome are encouraging and may suggest a 
higher clinical effect for repeated sessions of rTMS. 
Thanks to these first studies, rTMS offer a new insight 
in the treatment of patient with DOC. Nevertheless, it is still 
necessary to be cautious, since TMS can induce seizures, 
although the risk is very low as reviewed in the 2009 safety 
guidelines, that allows to further mitigate this issue.19 
Moreover, to confirm the efficacy of the technique, 
randomized placebo controlled studies should be 
performed in a wide population of patients. 
 
Transcranial Direct Current Stimulation (tDCS) 
In the past fifteen years, it has be shown by many studies 
that tDCS can modify neuronal excitability and induces 
behavioral changes (20-23). tDCS involves passing a weak 
(usually ≤ 2mA) direct current through the brain between 
two electrodes, the anode (i.e., excitatory) and the cathode 
(i.e., inhibitory). It is a safe, cheap and easy to use technique 
that could be easily integrated in rehabilitation programs. 
Currently, a lot of clinical trials have been conducted to 
study the effect of tDCS on post-stroke motor and language 
deficits, in psychiatric disorders, chronic pain, memory 
impairment and tinnitus in order to decrease symptoms 
(24-28). However, its therapeutic effect remains to be more 
extensively explored (29,30).  
Physiologically, anodal tDCS enhances excitability, 
whereas cathodal tDCS reduces it by decreasing or 
increasing the action potential threshold (31). The 
formation of the long-lasting after-effects is not entirely 
understood but seems to depend on membrane potential 
changes, modulations of NMDA receptors efficacy as well 
as modification of ion channels (e.g., calcium) (32). In 
another word, tDCS does not induce the firing of otherwise 
resting neurons, such as TMS, but it modulates the 
spontaneous firing rate of neurons by acting on the 
membrane potential.  
Several studies on patients with brain lesions have 
shown that a single of tDCS could improve the function of 
the stimulated area, such as motor function for a 
stimulation of the primary motor cortex (33) and memory 
(34,22) or attention (35) when the prefrontal cortex is 
stimulated. Nevertheless, the effects decrease between one 
and two hours after the stimulation (36) To solve this 
problem, researchers performed repeated tDCS protocols 
using daily stimulation for one (24), two (37), or three weeks 
(38). Consequently, the effects lasted until 4 weeks after the 
end of the stimulations.  
Nowadays, only a few studies tested the potential 
therapeutic effects of tDCS in patients with DOC. One of 
them explored the effect of a single session of anodal tDCS 
during 20 minutes over the left DLPF cortex on 55 patients 
with DOC (30 MCS, 25 VS/UWS, 25 post-TBI, 35 
chronic) (39). One anodal and one sham stimulations were 
performed in a randomized order, preceded and followed 
by a behavioral assessment using the CRS-R (40). 13 (43%) 
patients in MCS and 2 (8%) patients in VS/UWS further 
showed post-anodal tDCS related signs of consciousness, 
which were neither observed during the pre-tDCS 
evaluation nor during the pre- or post-sham evaluation (i.e., 
tDCS responder). Out of the 13 MCS responders, 5 were 
included more than 12 months after injury. This suggests 
that (i) tDCS could be useful in chronic setting and (ii) that 
some chronic patients in MCS could still improve even 
years after the injury. 
Another study tested 5 days of anodal tDCS for 20 
minutes per day, 5 days per week, for 2 weeks in 10 patients 
with DOC (7 VS/UWS and 3 MCS) (41). They stimulated 
the left primary sensorimotor cortex (M1–n=5) or the left 
dorsolateral prefrontal cortex (DLPC–n=5). The three 
MCS patients included in this study showed clinical 
improvement immediately after treatment and the effect 
lasted one week (2 received a stimulation over left M1 and 
1 over left DLPF). On the other hand, no patient in 
VS/UWS showed immediate enhancement after 
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stimulation, except for 1 patient who was in VS/UWS for 6 
years and showed improvement and change of status to 
MCS at 12-month follow-up (41).  
The outcomes of these two studies showed that tDCS 
could induce behavioral improvement in severely brain-
injured patients with DOC. However, the underlying 
mechanisms are still poorly understood. Further studies 
investigating the effect of repeated stimulations of the 
prefrontal, motor or other cortical areas, supported by 
neuroimaging, could help clinicians to choose the best area 
to stimulate according to patients’ brain lesion. 
As said above, the way tDCS induces behavioral 
improvement is only partially understood. Moreover, not 
all patients are willing to positively respond to tDCS. The 
proportion of tDCS responders vary from 40 to 80% (42-
44). Trying to define the structural and functional brain 
features of patients in MCS who are likely to respond to 
tDCS, a multi-modal neuroimaging study was performed to 
characterize the subgroup of tDCS responders previously 
describe in Thibaut et al (39). Using Fludeoxyglucose 
Positron Emission Tomography (FDG-PET) and Magnetic 
Resonance Imaging (MRI; more specifically Voxel Based 
Morphometry – VBM), they compared 8 tDCS responders 
with 13 non-responders (45).  
They identified that tDCS responders showed a partial 
metabolic (FDG-PET) and grey matter (VMB) 
preservation as compared to tDCS non-responders in three 
brain regions involved in consciousness processes (46): (i) 
left DLPF cortex (presumed stimulated area), (ii) 
precuneus, and (iii) thalamus (Figure 2). These findings 
highlight the importance of a partial preservation, both 
structural and functional, of the stimulated area in order to 
observe an improvement of signs of consciousness 
following tDCS in patients in MCS. Note that these results 
are only valid at the group level, and not at the single subject 
level. Further studies to detect specific patterns to predict 
the outcome at the individual level are warranted.  
Beside treatment purpose, tDCS has been studied as a 
potential diagnostic tool. Such as for TMS, tDCS was used 
to study brain response of MCS and VS/UWS patients. In 
a recent study, TMS was performed before and after tDCS 
over the orbitofrontal cortex to assess the cortical response 
to tDCS and the difference between MCS (n=5) and 
VS/UWS (n=7) patients. The authors identified an increase 
in MEP amplitude, an intracortical facilitation, as well as a 
premotor-motor inhibition reduction in patients in MCS. 
For three VS/UWS patients tDCS had no effect, whereas 
the other four showed a similar pattern as MCS patients. 
They also found that high CRS-R total scores were 
associated with better premotor-motor connectivity and M1 
excitability modulation. By means of these results, tDCS 
seems to be an interesting tool to characterize patients’ 
brain response to this stimulation and differentiate MCS 
from VS/UWS. Indeed, anodal tDCS induced an increase 
in cortical connectivity and excitability in MCS, while no 
improvement was observed for patients clinically diagnose 
as being in VS/UWS, except for some VS/UWS patients 
who may be misdiagnosed due to an absence of clinical 
behavior. 
 
Deep Brain Stimulation (DBS) 
DBS is widely used to treat several neurological and 
psychiatric disorders such as motor disorders (e.g., essential 
tremor, dystonia, Parkinson’s disease), chronic pain, or 
obsessive-compulsive disorders and is FDA approved (47). 
However, DBS for patients in MCS is still rarely 
performed. Basically, DBS encompasses a pulse generator 
that sends current to a brain electrode that delivers 
electrical and magnetic impulses in the targeted brain 
region. For some diseases, like Parkinson`s and Dystonia, 
DBS inhibits the targeted regions, while for other diseases 
it has an excitatory purpose. There are two main 
hypotheses to explain the effect of DBS. The first one 
supports the idea that the current sends through implanted 
electrodes can induce a transient blockade of voltage-gated 
currents and, therefore, limits the neural output in the area 
near to the electrodes (48). The second hypothesis is the 
synaptic depression or inhibition (49). In this case, the 
neural activation or deactivation is regulated indirectly by 
the activation or deactivation of axon terminals which 
modulates the synaptic connections with the neurons near 
the stimulation electrode. Nevertheless, the underlying 
mechanisms of DBS are not yet fully understood and 
mainly depend of the target pathology.  
By means of neuroimaging techniques, researchers 
have investigated the effect of DBS on patients’ brain 
activity. Recent studies highlighted that DBS induces a 
restoration of normal activity in the network involved in the 
targeted brain regions, depending on the specific pathology 
(50).  
DBS for patients in MCS aims at stimulating neural 
circuits responsible for attention, memory, language, or 
executive functions, by implanting electrodes in the 
intralaminar nuclei of the thalamus. This area was chosen 
for several reasons.51 First, the central thalamus is 
suggested to be altered in regards to the pathophysiological 
mechanisms linked to the brain injury. Moreover, cellular 
loss in central thalamus seems to be particularly associated 
with DOC patients’ level of recovery (52,53) That is why a 
brain injury can lead to a decrease in forebrain activity. 
Central and intralaminar nuclei neurons release an 
excitatory neurotransmitter, glutamate. DBS could facilitate 
the induction and support the activity in a large network of 
neurons through the entire brain and thus lead to the 
recovery of cognitive functions underlined by these 
networks. Finally, chronic DBS could have long-term 
behavioral effects, such as those observed in the study of 
Schiff et al (54).  These long-term  effects suggest a  possible 
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phenomenon. This last hypothesis has yet to be studied. 
The first DBS studies in DOC were performed in the 
1960’s and 1970’s and focused on the reticular formation, 
the basal ganglia, and especially, on the thalamus of TBI 
patients in VS/UWS (55-57) However, their clinical results 
and the long-term follow-up were incomplete and 
suboptimal. Moreover the specificity of the stimulation was 
inaccurate. In the 1980’s a multicentric study was initiated 
(58). It explored the effect of unilateral DBS electrodes 
placed either in the centromedian thalamus or dorsal 
columns of the cervical spinal cord in 25 patients in chronic 
(3-6 months post insult) VS/UWS following a TBI. The 
result failed to demonstrate any clinical improvements 
related to DBS.  
In the 1990’s, a Japanese team conducted multiple 
studies on DBS. In the first one, they stimulated the 
midbrain reticular formation (cuneiform nucleus) and 
unspecific thalamic nuclei (median-parafascicular complex) 
in 8 patients in VS/UWS (2–3 months post injury) (59). 
Interestingly, 3 patients showed behavioral improvement. 
However, even though some changes have been observed 
directly after the activation of the DBS device, most 
behavioral improvements were recorded only after 3–4 
months of treatment. Other studies have shown similar 
results (60,61) Since the reported improvements appeared 
within a one-year post injury period, during which a 
spontaneous recovery is most likely to appear, the observed 
improvements could also be explained, entirely or partially, 
by this phenomenon. Moreover, all these studies were not 
placebo-controlled. More recently, DBS of the midbrain 
reticular formation and the median-parafascicular complex 
was studied in 21 VS/UWS and 5 MCS patients (62) 8 
patients in VS/UWS recovered a response to commands 
(i.e., MCS+) and 4 patients in MCS recovered a functional 
communication (i.e., emerged from MCS).  
In 2007, Schiff and collaborators have reported the case 
of a chronic posttraumatic patient treated with DBS of 
thalamic intralaminar nuclei in a double-blind design with 
recording of several baselines (54) This was the first study 
that employed standardized reliable and validated outcome 
measures (such as the CRS-R40) to investigate the 
effectiveness of DBS. Clinically, the patient was in a 
minimally conscious state for 6 years and did not show any 
improvement despite rehabilitation program. Deep brain 
stimulation was applied bilaterally to the central thalamus 
and alternated on and off phases in 30-days intervals over 6 
months. Intelligible verbalizations and functional object use 
were directly observed. After a few months of stimulations, 
responses to command, spontaneous limb movements, 
oral feeding, and functional communication were 
objectified during DBS-on periods. When DBS was turned 
off, behavioral performance decreased significantly but 
remained above baseline level, suggesting remnant effects. 
These functional gains were maintained across the 24-
months follow-up phase. These findings are very 
encouraging for the therapy and the recovery of chronic 
patients with DOC. Even if DBS is very invasive, the post-
operative side-effects are limited. 
DBS expose the patient to more risks due to the brain 
surgery than rTMS or tDCS but can stimulate the brain 
centrally, in the thalamus and activate the thalamo-cortical 
connectivity, which has a critical role for consciousness 
recovery (46,63). Finally, let’s not forget that inclusion 
criteria to receive this stimulation (e.g., preserved 
metabolism in the thalamus) are very strict and the majority 
of patients cannot benefit from this therapy. 
 
 
The Mesocircuit Model 
A hypothesis to explain the mechanisms of action of 
another treatment for patients with DOC, zolpidem (i.e., 
sedative drugs showing paradoxical responses in rare cases 
of MCS patients (39), is the mesocircuit model (40,41). The 
mesocircuit hypothesis supports the idea that, in normal 
cognitive processing, the striatum disinhibits the central 
thalamus via the internal globus pallidus (GPi) while the 
central thalamus promotes activity of associative cortical 
areas (40). A deafferentation and loss of neurons due to a 
severe brain injury could induce a reduction of thalamo-
cortical and thalamo-striatal connectivity. This will reduce 
important afferent drive to the striatum and, as a 
consequence, reduce the activity of the central thalamic and 
associative areas. According to the mesocircuit hypothesis, 
Zolpidem could inhibit the GPi and decrease the inhibition  
Figure 2: Positron emission tomography (PET): Brain areas showing 
hypometabolism (in blue), as compared to controls, in patients in a 
minimally conscious state (FEW corrected): (A) 8 tDCS-responders 
and (B) 13 non-responders. (C) Regions with less hypometabolism in 
responders as compared to non-responders (in red). (D) Theoretical 
(Ruffini, Fox et al. 2014) tDCS induced electric fields. Note that 
behavioural responsiveness to short duration left dorsolateral 
prefrontal cortex (DLPFC) tDCS correlates with less impaired 
metabolism in the areas presumed to be stimulated by tDCS (left 
DLPFC and mesiofrontal cortices) but also of distant cortical 
(precuneus) and subcortical (thalamus) regions. From Thibaut et al. 
2015. 
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of the thalamus. If the inhibition is decreased, the frontal 
area could recover its activity (41). This model provides an 
explanation of the vulnerability of frontal regions in case of 
extensive deafferentation with loss of neurons due to severe 
brain damage observed in patients with DOC (figure 3).  
Interestingly, all brain stimulations techniques, rTMS, 
tDCS and DBS, were performed over brain regions 
involved in the mesocircuit model. Indeed, rTMS acts on 
neuronal activity and tDCS increase neuronal excitability of 
the prefrontal cortex, while DBS directly stimulate the 
thalamus. These observations are in line with the study of 
Laureys et al. where a recovery of the connectivity between 
the thalamus and the frontal area was detected.46 By 
stimulating the thalamus this reconnection could be 
restored. Still, prefrontal areas are important in cognitive 
processes (64) and their stimulation seems to improve 
consciousness as well, though at a lower level. The 
mesocircuit model, by integrating this fronto-striato-
thalamic loop, seems to explain the effects of several 
treatments to improve signs of consciousness of patients 
with DOC and highlights once more the critical role of the 




All these neuro-stimulation techniques are still at their 
infancy and many studies need to be done to explore all the 
potentialities and parameters that would be the most 
efficient for patient with DOC.  
Concerning, rTMS and tDCS further studies 
investigating the long term effect of these techniques, and 
their value in clinical practice, are highly required. Others 
areas of stimulations could also be tested according to 
patients’ cortical damage. Based on the functional and 
structural brain signature of tDCS responders, it seems that 
patients need a partial preservation of the stimulated area 
to clinically respond to tDCS. Suggesting that, a stimulation 
of a (partially) preserved area would be more effective than 
stimulating a damaged brain region. Studies using 
neuroimaging (MRI, PET and HD-EEG) performed 
before and after a stimulation should be carried out. This 
will give the opportunity to investigate the direct effect of 
tDCS, or rTMS, on patients’ brain and better characterize 
which area to stimulate according to patients’ cerebral 
lesion. The final aim would be to develop a patients’ 
tailored stimulation in order to give them the best chance 
to recovery a certain degree of autonomy.  
Concerning DBS, clinical trials including a larger 
population of patients with less restrictive inclusion criteria 
should be performed. This would be the first step to know 
if DBS could be used as a common treatment for chronic 
patients with DOC. However, the cost and the risk linked 
to this technique are important limiting factors. 
In conclusion, more work has to be done to strengthen 
our understanding of potential treatments to promote the 
recovery of consciousness in patients with DOC. The 
previously discussed neuro-stimulation techniques are 
thought to excite mainly the forebrain regions and restore 
the connectivity between the thalamus and prefrontal 
cortex. Our understanding of neuronal correlate of 
consciousness recovery could help neuroscientists and 
clinicians to find new ways to treat patients. On the other 
hand, understand the mechanism of how these therapies 
work may help to understand the phenomena occurring in 
the process of recovery of consciousness. 
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